Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.51
-0.01 (-0.66%)
At close: Jun 17, 2025, 2:20 PM
-0.66% (1D)
| Bid | 1.48 |
| Market Cap | 17.09M |
| Revenue (ttm) | 5.7M |
| Net Income (ttm) | -12.78M |
| EPS (ttm) | -1.32 |
| PE Ratio (ttm) | -1.14 |
| Forward PE | -0.92 |
| Analyst | Strong Buy |
| Ask | 1.52 |
| Volume | 85,136 |
| Avg. Volume (20D) | 105,996 |
| Open | 1.67 |
| Previous Close | 1.52 |
| Day's Range | 1.51 - 1.53 |
| 52-Week Range | 0.95 - 5.99 |
| Beta | 1.45 |
About MRKR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+33.33%
Marker Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
-7.44%
Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.